Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trial

Efficacy of Olanzapine Combined Therapy for Patients Receiving Highly Emetogenic Chemotherapy Resistant to Standard Antiemetic Therapy

(2015) Masakazu Abe et al.   Biomed Research International

Efficacy and safety of triple therapy with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy for gynecological cancer: KCOG-G1003 phase II trial

(2014) Nobuhiro Takeshima et al.   SUPPORTIVE CARE IN CANCER

The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy

(2013) Rudolph M. Navari et al.   SUPPORTIVE CARE IN CANCER

Olanzapine for the Relief of Nausea in Patients With Advanced Cancer and Incomplete Bowel Obstruction

(2012) Keisuke Kaneishi et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

(2011) Ethan Basch et al.   JOURNAL OF CLINICAL ONCOLOGY

Positron Emission Tomography Measurement of Dopamine D2Receptor Occupancy in the Pituitary and Cerebral Cortex

(2010) Ryosuke Arakawa et al.   JOURNAL OF CLINICAL PSYCHIATRY

Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy

(2010) Flavia Longo et al.   SUPPORTIVE CARE IN CANCER

Anticipatory nausea and vomiting

(2010) Joseph A. Roscoe et al.   SUPPORTIVE CARE IN CANCER

Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting

(2009) Lijun Tan et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial

(2009) Mitsue Saito et al.   LANCET ONCOLOGY

Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trial

(2009) Rudolph M. Navari et al.   SUPPORTIVE CARE IN CANCER